Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to Pegylated Interferon and Ribavirin in Chinese Chronic Hepatitis C
NCT01433887Phase 3Completed
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2011
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Started Nov 2011; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01433887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433887.